drugset / Trial / NCT00191841
Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To evaluate the clinical response rate of neoadjuvant chemotherapy with gemcitabine and cisplatin in patients with operable NSCLC
Timeline
- Start
- 2002-12
- Primary completion
- —
- Completion
- 2006-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 75 mg/m2 | — |
| Subject | Gemcitabine | Small molecule | 1000 mg/m2 | — |